BioCryst Pharmaceuticals, Inc. (BCRX)

BioCryst Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,474	1,227	2,140	2,492	1,315	381
Market Cap Growth	-33.37%	-42.68%	-14.12%	89.45%	245.24%	-56.94%
Enterprise Value	1,988	1,685	2,456	2,574	1,292	328
PE Ratio	-	-5.41	-8.66	-13.54	-7.19	-3.50
PS Ratio	4.15	3.70	7.90	15.86	73.85	7.80
PB Ratio	-2.20	-2.69	-7.26	-23.29	-68.29	9.96
P/FCF Ratio	-10.11	-12.61	-13.11	-17.24	-9.70	-4.24
P/OCF Ratio	-10.34	-12.89	-13.22	-17.53	-9.74	-4.25
EV/Sales Ratio	5.59	5.08	9.07	16.38	72.55	6.71
EV/EBITDA Ratio	-15.36	-14.48	-17.07	-21.15	-7.71	-3.41
EV/EBIT Ratio	-15.13	-14.28	-16.90	-21.01	-7.68	-3.38
EV/FCF Ratio	-15.08	-17.31	-15.05	-17.81	-9.53	-3.65
Debt / Equity Ratio	-1.79	-1.86	-2.52	-5.55	-14.51	2.21
Debt / EBITDA Ratio	-8.39	-7.30	-5.15	-4.87	-1.67	-0.88
Debt / FCF Ratio	-8.24	-8.72	-4.54	-4.10	-2.06	-0.94
Quick Ratio	3.33	2.99	4.51	5.21	2.95	1.73
Current Ratio	3.73	3.31	4.89	5.46	3.07	1.78
Asset Turnover	0.70	0.64	0.51	0.44	0.08	0.37
Interest Coverage	-0.98	-1.09	-1.47	-2.07	-11.61	-8.16
Return on Equity (ROE)	48.20%	57.20%	108.10%	169.20%	-773.60%	-4223.70%
Return on Assets (ROA)	-40.90%	-43.60%	-46.00%	-52.00%	-84.80%	-83.10%
Return on Capital (ROIC)	-23.83%	-26.38%	-33.22%	-36.55%	-67.15%	-80.92%
Earnings Yield	-14.16%	-18.47%	-11.55%	-7.39%	-13.90%	-28.58%
FCF Yield	-7.03%	-7.93%	-7.63%	-5.80%	-10.31%	-23.60%
Buyback Yield / Dilution	-9.31%	-3.38%	-3.79%	-7.08%	-44.69%	-12.03%
Total Shareholder Return	-9.31%	-3.38%	-3.79%	-7.08%	-44.69%	-12.03%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).